• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲型流感病毒逃逸突变体在存在针对基质蛋白2胞外域的抗体的情况下于体内出现。

Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2.

作者信息

Zharikova Darya, Mozdzanowska Krystyna, Feng Jingqi, Zhang Manxin, Gerhard Walter

机构信息

The Wistar Institute, 3601 Spruce St., Philadelphia, PA 19104-4268, USA.

出版信息

J Virol. 2005 Jun;79(11):6644-54. doi: 10.1128/JVI.79.11.6644-6654.2005.

DOI:10.1128/JVI.79.11.6644-6654.2005
PMID:15890902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1112148/
Abstract

The ectodomain of matrix protein 2 (M2e) of human influenza type A virus strains has remained remarkably conserved since 1918. Because M2e-specific immunity has been shown to decrease morbidity and mortality associated with influenza virus infection in several animal models and because natural infection and current vaccines do not appear to induce a good M2e-specific antibody (Ab) response, M2e has been considered as potential vaccine for inducing cross-reactive protection against influenza type A viruses. The high degree of structural conservation of M2e could in part be the consequence of a poor M2e-specific Ab response and thus the absence of pressure for change. To assess this possibility, we studied the course of infection in SCID mice in the presence or absence of passive M2e-specific monoclonal Abs (MAbs). We found that virus mutants with antigenic changes in M2e emerged in 65% of virus-infected mice treated with M2e-specific but not control MAbs. However, the diversity of escape mutants was highly restricted since only two types were isolated from 22 mice, one with a proline-to-leucine and the other with a proline-to-histidine interchange at amino acid position 10 of M2e. The implications of these findings for the use of M2e as a broadly protective vaccine are discussed.

摘要

自1918年以来,甲型人流感病毒株基质蛋白2(M2e)的胞外域一直保持着显著的保守性。由于在多种动物模型中,M2e特异性免疫已被证明可降低与流感病毒感染相关的发病率和死亡率,且自然感染和现有疫苗似乎都不能诱导良好的M2e特异性抗体(Ab)反应,因此M2e被认为是诱导针对甲型流感病毒的交叉反应性保护的潜在疫苗。M2e高度的结构保守性可能部分是由于M2e特异性Ab反应较差,因此缺乏变异压力所致。为评估这种可能性,我们研究了在有无被动给予的M2e特异性单克隆抗体(MAb)情况下,SCID小鼠的感染过程。我们发现,在用M2e特异性而非对照MAb处理的65%的病毒感染小鼠中出现了M2e抗原性发生变化的病毒突变体。然而,逃逸突变体的多样性受到高度限制,因为从22只小鼠中仅分离出两种类型,一种是M2e第10位氨基酸处脯氨酸变为亮氨酸,另一种是脯氨酸变为组氨酸。本文讨论了这些发现对将M2e用作广泛保护性疫苗的意义。

相似文献

1
Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2.甲型流感病毒逃逸突变体在存在针对基质蛋白2胞外域的抗体的情况下于体内出现。
J Virol. 2005 Jun;79(11):6644-54. doi: 10.1128/JVI.79.11.6644-6654.2005.
2
Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression.M2e 特异性 IgG 治疗选择具有延迟基质蛋白 2 表达的流感 A 病毒突变体。
mBio. 2021 Aug 31;12(4):e0074521. doi: 10.1128/mBio.00745-21. Epub 2021 Jul 13.
3
Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin.基于与鞭毛蛋白连接的异源M2e肽的候选重组疫苗诱导的对多种甲型流感病毒株的保护作用。
PLoS One. 2015 Mar 23;10(3):e0119520. doi: 10.1371/journal.pone.0119520. eCollection 2015.
4
Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection.多个异源 M2 细胞外结构域呈现在病毒样颗粒上比活流感病毒感染赋予更广泛和更强的 M2 免疫。
Antiviral Res. 2013 Sep;99(3):328-35. doi: 10.1016/j.antiviral.2013.06.010. Epub 2013 Jun 27.
5
Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection.基于甲型流感病毒基质蛋白 2 胞外域的通用疫苗:Fc 受体和肺泡巨噬细胞介导保护作用。
J Immunol. 2011 Jan 15;186(2):1022-31. doi: 10.4049/jimmunol.0902147. Epub 2010 Dec 17.
6
An influenza A virus vaccine based on an M2e-modified alphavirus.一种基于M2e修饰的甲病毒的甲型流感病毒疫苗。
Arch Virol. 2018 Feb;163(2):483-488. doi: 10.1007/s00705-017-3578-8. Epub 2017 Oct 27.
7
Fine specificity and sequence of antibodies directed against the ectodomain of matrix protein 2 of influenza A virus.针对甲型流感病毒基质蛋白2胞外域的抗体的精细特异性和序列
Mol Immunol. 2006 Jul;43(14):2195-206. doi: 10.1016/j.molimm.2005.12.015. Epub 2006 Feb 10.
8
Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein.一种针对甲型流感病毒M2蛋白的全人源单克隆抗体的治疗潜力。
Antiviral Res. 2008 Nov;80(2):168-77. doi: 10.1016/j.antiviral.2008.06.002. Epub 2008 Jul 1.
9
Characterization of the murine Th2 response to immunization with liposomal M2e influenza vaccine.检测用脂质体 M2e 流感疫苗免疫后小鼠 Th2 反应的特征。
Vaccine. 2011 Jun 15;29(27):4460-8. doi: 10.1016/j.vaccine.2011.04.040. Epub 2011 May 3.
10
Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats.利用表达 NP 和 M2 胞外域串联重复的重组痘苗病毒疫苗提高对流感病毒的交叉保护作用。
Virol Sin. 2019 Oct;34(5):583-591. doi: 10.1007/s12250-019-00138-9. Epub 2019 Jun 25.

引用本文的文献

1
Adjuvant-free, self-assembling ferritin nanoparticle vaccine coupled with influenza virus hemagglutinin protein carrying M1 and PADRE epitopes elicits cross-protective immune responses.不含佐剂、自组装的铁蛋白纳米颗粒疫苗与携带M1和PADRE表位的流感病毒血凝素蛋白偶联,可引发交叉保护性免疫反应。
Front Immunol. 2025 Jan 31;16:1519866. doi: 10.3389/fimmu.2025.1519866. eCollection 2025.
2
Vaccination against swine influenza in pigs causes different drift evolutionary patterns upon swine influenza virus experimental infection and reduces the likelihood of genomic reassortments.猪流感疫苗接种会导致猪流感病毒实验感染时的不同漂移进化模式,并降低基因组重配的可能性。
Front Cell Infect Microbiol. 2023 Mar 13;13:1111143. doi: 10.3389/fcimb.2023.1111143. eCollection 2023.
3
Emergence of a unique SARS-CoV-2 Delta sub-cluster harboring a constellation of co-appearing non-Spike mutations.出现了一种独特的 SARS-CoV-2 Delta 亚群,其中包含一系列同时出现的非 Spike 突变。
J Med Virol. 2023 Jan;95(1):e28413. doi: 10.1002/jmv.28413.
4
Bioinformatic analysis of PD-1 checkpoint blockade response in influenza infection.PD-1 检查点阻断反应在流感感染中的生物信息学分析。
BMC Genom Data. 2022 Aug 13;23(1):65. doi: 10.1186/s12863-022-01081-7.
5
The adaptation of SARS-CoV-2 to humans.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)对人类的适应性。
Mem Inst Oswaldo Cruz. 2022 Jan 10;116:e210127. doi: 10.1590/0074-02760210127. eCollection 2022.
6
Bacteriophage T4 Vaccine Platform for Next-Generation Influenza Vaccine Development.基于噬菌体 T4 的疫苗平台在下一代流感疫苗研发中的应用。
Front Immunol. 2021 Oct 12;12:745625. doi: 10.3389/fimmu.2021.745625. eCollection 2021.
7
Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression.M2e 特异性 IgG 治疗选择具有延迟基质蛋白 2 表达的流感 A 病毒突变体。
mBio. 2021 Aug 31;12(4):e0074521. doi: 10.1128/mBio.00745-21. Epub 2021 Jul 13.
8
Matrix Protein 2 Extracellular Domain-Specific Monoclonal Antibodies Are an Effective and Potentially Universal Treatment for Influenza A.基质蛋白2细胞外区域特异性单克隆抗体是甲型流感的一种有效且可能通用的治疗方法。
J Virol. 2021 Mar 1;95(5). doi: 10.1128/JVI.01027-20. Epub 2020 Dec 2.
9
Engineered Nanoparticle Applications for Recombinant Influenza Vaccines.工程纳米颗粒在重组流感疫苗中的应用。
Mol Pharm. 2021 Feb 1;18(2):576-592. doi: 10.1021/acs.molpharmaceut.0c00383. Epub 2020 Aug 17.
10
Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics.针对流感病毒的广泛保护策略:通用疫苗与治疗方法。
Front Microbiol. 2020 Feb 7;11:135. doi: 10.3389/fmicb.2020.00135. eCollection 2020.

本文引用的文献

1
Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys.甲型流感病毒M2肽偶联疫苗在小鼠、雪貂和恒河猴中的临床前研究。
Vaccine. 2004 Aug 13;22(23-24):2993-3003. doi: 10.1016/j.vaccine.2004.02.021.
2
Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge.识别甲型流感病毒M2蛋白EVETPIRN表位的单克隆抗体可保护小鼠免受致死性甲型流感病毒攻击。
Immunol Lett. 2004 May 15;93(2-3):131-6. doi: 10.1016/j.imlet.2004.03.003.
3
Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity.基于M2细胞外结构域的甲型流感疫苗:通过抗体依赖性自然杀伤细胞活性介导的微弱保护作用。
J Immunol. 2004 May 1;172(9):5598-605. doi: 10.4049/jimmunol.172.9.5598.
4
Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion.流感病毒血凝素聚集在脂筏微区以实现高效的病毒融合。
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):14610-7. doi: 10.1073/pnas.2235620100. Epub 2003 Oct 15.
5
Virus-neutralizing activity mediated by the Fab fragment of a hemagglutinin-specific antibody is sufficient for the resolution of influenza virus infection in SCID mice.血凝素特异性抗体的Fab片段介导的病毒中和活性足以解决SCID小鼠中的流感病毒感染。
J Virol. 2003 Aug;77(15):8322-8. doi: 10.1128/jvi.77.15.8322-8328.2003.
6
Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2.用包含基质蛋白2胞外域的合成多抗原肽疫苗免疫小鼠诱导甲型流感病毒特异性抗性。
Vaccine. 2003 Jun 2;21(19-20):2616-26. doi: 10.1016/s0264-410x(03)00040-9.
7
N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication.M2蛋白的N端可诱导产生具有抑制流感病毒复制活性的抗体。
FEMS Immunol Med Microbiol. 2003 Mar 20;35(2):141-6. doi: 10.1016/S0928-8244(03)00009-9.
8
Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus.用表达流感病毒M2-核蛋白融合蛋白的DNA构建体对猪进行疫苗接种,会在感染甲型流感病毒后加剧疾病。
J Gen Virol. 2002 Aug;83(Pt 8):1851-1859. doi: 10.1099/0022-1317-83-8-1851.
9
Universal primer set for the full-length amplification of all influenza A viruses.用于甲型流感病毒全长扩增的通用引物组。
Arch Virol. 2001 Dec;146(12):2275-89. doi: 10.1007/s007050170002.
10
Complement component C1q enhances the biological activity of influenza virus hemagglutinin-specific antibodies depending on their fine antigen specificity and heavy-chain isotype.补体成分C1q根据流感病毒血凝素特异性抗体的精细抗原特异性和重链同种型增强其生物活性。
J Virol. 2002 Feb;76(3):1369-78. doi: 10.1128/jvi.76.3.1369-1378.2002.